Adaptive transfer of CD23+CD43+ B cells significantly reduced the severity of colitis (Figure 9; p<0.01 or p<0.05), indicating that CD23+CD43+ B cells might be the hMSC-induced Breg cells that can effectively mitigate the mucosal inflammatory response. The gene discussed is FCER2; the disease is colitis.